$14m invested to create vaccine for debilitating periodontal gum disease

Sep 26, 2019
Denteric launch A vaccine for periodontal gum disease, which affects a third of all adults globally, is in development following a $14 million investment into newly-formed biotech company Denteric Pty Ltd.

Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies.